GlassScriptPhysician profile
Diana E Mcshane
NPI 1902368780
$2,313.87
in general payments reported to CMS, 2019-2025
9 companies · $1,902 in 2025
The $1,902 reported for 2025 was more than what 85% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $331 · 2024: $80.20 · 2025: $1,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,313.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,851.78 | 2025 | Senza |
| Nevro Corp. | $107.05 | 2023 | Senza |
| Stryker Corporation | $93.02 | 2023 | Spinejack, Omnicurve, Optablate |
| Spr Therapeutics, INC | $86.18 | 2023-2024 | Sprint Pns System |
| Relievant Medsystems, INC. | $75.69 | 2023 | Intracept |
| Merz Pharmaceuticals, LLC | $35.48 | 2023 | Xeomin |
| Abbvie INC. | $34.84 | 2025 | |
| Ibsa Pharma INC. | $15.56 | 2025 | Tirosint, Licart, Flector |
| Medtronic, INC. | $14.27 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Mcshane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.